Mission and Scope

The Biosafety Program supports the University of Virginia (UVA) community by fostering safe and responsible research, clinical, teaching, and operational activities involving biological agents, recombinant or synthetic nucleic acids, biological toxins, and related materials. Through guidance, education, and collaboration, the program helps protect faculty, staff, students, patients, visitors, the public, and the environment while supporting compliance with applicable federal, state, local, and University biosafety requirements.

The scope of this SLC includes advisory, review, oversight, training coordination, incident response, and recordkeeping functions associated with biosafety and biosecurity activities conducted under UVA authority. 

Services Provided

The UVA Biosafety Program provides the following services: 

  • Institutional Biosafety Committee (IBC) administration 

    • Pre-review and administrative support for IBC protocols involving recombinant or synthetic nucleic acids, infectious agents, and select biological materials. 

    • Tracking of protocol approvals, amendments, renewals, and closures. 

  • Protocol review and consultation 

    • Scientific and regulatory guidance during protocol development 

    • Risk assessments for biological materials, procedures, and containment levels 

    • Determination of appropriate Biosafety Level (BSL) and containment controls 

  • Laboratory registration and inventory oversight 

    • Registration of laboratories conducting biosafety-regulated activities 

    • Maintenance of records related to biological agents, toxins, and approvals 

  • Laboratory inspections and assessments 

    • Routine biosafety inspections of registered laboratories 

    • Follow-up inspections and corrective action verification 

    • Pre-occupancy and change-of-use laboratory consultations 

  • Training coordination 

    • Assignment and tracking of required biosafety training 

    • Coordination with EHS training platforms and external resources as applicable 

  • Incident response and exposure management support 

    • Consultation following spills, exposures, releases, or procedural deviations 

    • Coordination with Occupational Health, Risk Management, and EHS leadership as needed 

    • Incident documentation and reporting support 

  • Policy, guidance, and program development 

    • Development and maintenance of biosafety policies, SOP templates, and guidance documents 

    • Interpretation of evolving biosafety regulations and standards 

  • Regulatory support and reporting 

    • Support for compliance with NIH Guidelines, CDC/NIH BMBL, OSHA standards, and other applicable requirements 

  • Assistance with required notifications to funding agencies or regulatory bodies, when applicable 

Service Response Expectations

Biosafety service requests are submitted via established EHS service channels (email, phone, or electronic systems). Requests are triaged and prioritized based on exposure risks, regulatory-related deadlines, research activities, and consultation needs.

  • Emergent incidents or suspected exposures: 
    • Initial response initiated as soon as possible during business hours; next-business-day response after hours 
    • Interviews with affected person occurs within 1 week of biosafety notification
  • New IBC protocol submissions: 
    • Administrative pre-review feedback provided within five business days of complete submission 
    • IBC review during next meeting.  Typically occurs within 30 days depending on the timing of the submission. 
  • IBC protocol amendments and renewals: 
    • Initial administrative review within five business days 
    • IBC review during next meeting.  Typically occurs within 30 days.
  • Laboratory biosafety inspections: 
    • Scheduled based on risk level and inspection cycle
      • Monthly inspections scheduled during the last week of the previous month
      • Pre-inspections scheduled once a lab is set up and waiting for IBC review
      • Unannounced visits may occur anytime there may be reported issues.
    • A follow-up email with corrections is issued within five business days of an inspection.
  • General consultation requests acknowledged within a business day and occur within 5 days.

Timelines may vary based on volume, complexity, and completeness of submitted information. 

Regulatory and Policy References

  • NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules 
  • CDC/NIH Biosafety in Microbiological and Biomedical Laboratories (BMBL) 
  • OSHA Bloodborne Pathogens Standard (29 CFR 1910.1030) 
  • OSHA Hazard Communication Standard (29 CFR 1910.1200) 
  • Select Agent Regulations (42 CFR 73, 7 CFR 331, 9 CFR 121) 
  • USG Policy on Life Sciences for DURC and PEPP, as amended 
  • UVA Institutional Biosafety Committee policies and procedures 
  • UVA Policy SEC-012: Possession and Use of Biological Agents

Training

The Biosafety Program coordinates and tracks required training, which may include: 

  • General Biosafety Training 

  • Bloodborne Pathogens Training 
  • Agent- or procedure-specific biosafety training 
  • Refresher training is required at intervals defined by regulation, policy, or risk level. 

Deliverables and Records Management

  • IBC approval letters 

  • Laboratory inspection reports and corrective action records

  • Incident and exposure documentation 

  • Training assignment and completion records 

 

Records are maintained in accordance with University records retention requirements.